Page last updated: 2024-10-31

metyrapone and Alloxan Diabetes

metyrapone has been researched along with Alloxan Diabetes in 3 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Costa Rosa, LF1
Cury, Y1
Curi, R1
Okamoto, K1
Church, MK1
James, GW1
Miller, P1

Reviews

1 review available for metyrapone and Alloxan Diabetes

ArticleYear
Spontaneous hypertension in rats.
    International review of experimental pathology, 1969, Volume: 7

    Topics: Adrenal Medulla; Animals; Antihypertensive Agents; Aorta; Arteries; Autonomic Agents; Body Weight; C

1969

Other Studies

2 other studies available for metyrapone and Alloxan Diabetes

ArticleYear
Hormonal control of macrophage function and glutamine metabolism.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 1991, Volume: 69, Issue:4

    Topics: Adrenalectomy; Animals; Cell Migration Inhibition; Diabetes Mellitus, Experimental; Epinephrine; Glu

1991
Proceedings: The inhibitory effect of insulin on pinnal anaphylaxis in the mouse.
    British journal of pharmacology, 1974, Volume: 52, Issue:3

    Topics: Adrenal Glands; Anaphylaxis; Animals; Diabetes Mellitus, Experimental; Ear; Histamine; Horses; Insul

1974